Octagon Capital Advisors LP
Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| ABIVAX SA(ABVX) | 1,267,000 | 1,325,000 | +58,000 | 9,692,550 | 112,492,500 | 17.56% | +102,799,950 |
| DIANTHUS THERAPEUTICS INC(DNTH) | 2,341,667 | 2,416,667 | +75,000 | 43,625,256 | 95,095,846 | 14.84% | +51,470,590 |
| GOSSAMER BIO INC | 18,350,000 | 17,050,000 | -1,300,000 | 22,570,500 | 44,841,500 | 7.00% | +22,271,000 |
| COGENT BIOSCIENCES INC(COGT) | 2,763,000 | 2,874,111 | +111,111 | 19,838,340 | 41,272,234 | 6.44% | +21,433,894 |
| CIDARA THERAPEUTICS INC(Call) | 0 | 200,000 | +200,000 | 0 | 19,152,000 | — | +19,152,000 |
| BRIDGEBIO ONCOLOGY THERAPEUT | 0 | 1,043,110 | +1,043,110 | 0 | 12,079,214 | 1.89% | +12,079,214 |
| MIND MEDICINE MINDMED INC | 2,130,000 | 2,130,000 | 0 | 13,823,700 | 25,112,700 | 3.92% | +11,289,000 |
| CIDARA THERAPEUTICS INC | 0 | 100,000 | +100,000 | 0 | 9,576,000 | 1.49% | +9,576,000 |
| KYMERA THERAPEUTICS INC(KYMR) | 266,000 | 360,000 | +94,000 | 11,608,240 | 20,376,000 | 3.18% | +8,767,760 |
| MERUS N V | 389,000 | 308,000 | -81,000 | 20,461,400 | 28,998,200 | 4.53% | +8,536,800 |
| OCULAR THERAPEUTIX INC(OCUL) | 2,425,000 | 2,624,000 | +199,000 | 22,504,000 | 30,674,560 | 4.79% | +8,170,560 |
| CENTESSA PHARMACEUTICALS PLC | 1,030,000 | 830,000 | -200,000 | 13,534,200 | 20,127,500 | 3.14% | +6,593,300 |
| CORBUS PHARMACEUTICALS HLDGS | 1,115,000 | 1,115,000 | 0 | 7,693,500 | 14,104,750 | 2.20% | +6,411,250 |
| PHARVARIS N V | 672,595 | 722,595 | +50,000 | 11,837,672 | 18,028,745 | 2.81% | +6,191,073 |
| TREVI THERAPEUTICS INC(TRVI) | 3,672,000 | 2,815,000 | -857,000 | 20,085,840 | 25,757,250 | 4.02% | +5,671,410 |
| APELLIS PHARMACEUTICALS INC | 903,500 | 903,500 | 0 | 15,639,585 | 20,446,205 | 3.19% | +4,806,620 |
| PEPGEN INC | 0 | 700,000 | +700,000 | 0 | 3,234,000 | 0.50% | +3,234,000 |
| STRUCTURE THERAPEUTICS INC | 0 | 115,000 | +115,000 | 0 | 3,220,000 | 0.50% | +3,220,000 |
| MAZE THERAPEUTICS INC(MAZE) | 177,667 | 177,667 | 0 | 2,179,974 | 4,606,905 | 0.72% | +2,426,931 |
| KALVISTA PHARMACEUTICALS INC | 1,273,333 | 1,273,333 | 0 | 14,395,030 | 15,509,196 | 2.42% | +1,114,166 |
| DBV TECHNOLOGIES S A | 1,018,021 | 1,018,021 | 0 | 9,314,892 | 10,180,210 | 1.59% | +865,318 |
| TAYSHA GENE THERAPIES INC(TSHA) | 12,592,500 | 9,067,500 | -3,525,000 | 29,088,675 | 29,650,725 | 4.63% | +562,050 |
| NUVATION BIO INC(NUVB) | 154,112 | 104,112 | -50,000 | 300,518 | 385,214 | 0.06% | +84,696 |
| NEUROGENE INC | 303,000 | 252,000 | -51,000 | 4,529,850 | 4,367,160 | 0.68% | -162,690 |
| UNICYCIVE THERAPEUTICS INC | 1,000,000 | 1,000,000 | 0 | 4,770,000 | 4,360,000 | 0.68% | -410,000 |
| ERASCA INC(ERAS) | 700,000 | 0 | -700,000 | 889,000 | 0 | — | -889,000 |
| KALARIS THERAPEUTICS INC | 360,000 | 0 | -360,000 | 961,200 | 0 | — | -961,200 |
| HELIX ACQUISITION CORP II | 250,000 | 0 | -250,000 | 2,662,500 | 0 | — | -2,662,500 |
| NUVATION BIO INC(NUVB) | 7,691,334 | 2,633,334 | -5,058,000 | 14,998,101 | 9,743,336 | 1.52% | -5,254,765 |
| ARRIVENT BIOPHARMA INC(AVBP) | 1,946,054 | 1,971,054 | +25,000 | 42,365,596 | 36,365,946 | 5.68% | -5,999,650 |
| MOONLAKE IMMUNOTHERAPEUTICS(MLTX) | 148,000 | 0 | -148,000 | 6,985,600 | 0 | — | -6,985,600 |
| TOURMALINE BIO INC | 905,000 | 0 | -905,000 | 14,470,950 | 0 | — | -14,470,950 |
| ATYR PHARMA INC | 3,820,000 | 0 | -3,820,000 | 19,367,400 | 0 | — | -19,367,400 |
| ARS PHARMACEUTICALS INC | 1,350,000 | 0 | -1,350,000 | 23,557,500 | 0 | — | -23,557,500 |
| VERONA PHARMA PLC | 337,000 | 0 | -337,000 | 31,873,460 | 0 | — | -31,873,460 |